News & analysis on the clinical development and manufacture of large molecule drugs
Hired and retired: Year’s end edition
By Ben Hargreaves
- Last updated on
(Image: Getty/Jongho Shin)
As we move closer to the end of the year, companies are assembling their boardrooms for the new year.
Gilead has revealed who will take up the mantle of CEO at the company while some smaller biotechs have made some big name appointments to bolster their executive boards. One privately held biotech has secured the services of Facebook’s CFO to steer the company in its aim to combat ageing.